Decorin and chondroitin sulfate distribution in vulvar lichen sclerosus: Correlation with distinct histopathologic stages

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 52, Issue 1, 2007, Pages 38-42

  Corrêa, Adriana C ^a   Azevedo, Lúcia ^b   Almeida, Gutemberg ^b   Do Val, Isabel ^b   Cuzzi, Tullia ^b   Takiya, Christina Maeda ^b  

^a NONE   (Brazil)

^b NONE

Author keywords

Chondroitin sulfate; Decorin; Glycosaminoglycans; Lichen sclerosus of vulva; Proteoglycans

Indexed keywords

CHONDROITIN SULFATE; DECORIN; PROTEOGLYCAN; SCLEROPROTEIN;

CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE CLASSIFICATION; EXTRACELLULAR MATRIX; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; LICHEN SCLEROSUS ET ATROPHICUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VULVA; ARTICLE; METABOLISM; PATHOLOGY; TISSUE DISTRIBUTION;

CHONDROITIN SULFATES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; PROTEOGLYCANS; TISSUE DISTRIBUTION; VULVAR LICHEN SCLEROSUS;

EID: 34047158237     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Powell JJ, Wojnarowska F: Lichen sclerosus. Lancet 1999;353:1777-1783
2. Hewitt J: Histologic criteria for lichen sclerosus of the vulva. J Reprod Med 1986;31:781-787
3. Farrell AM, Dean D, Millard PR, et al: Alterations in fibrillin as well as collagens I and III and elastin occur in vulval lichen sclerosus. J Eur Acad Dermatol Venereol 2001;15:212-217
4. Soini Y, Pöllänen R, Autio-Harmainen H, et al: Tenascin expression in lichen sclerosus. Int J Gynecol Pathol 1997;16:313-318
5. Farrell AM, Dean D, Charnock FM, et al: Alterations in distribution of tenascin, fibronectin and fibrinogen in vulval lichen sclerosus. Dermatology 2000;201:223-229
6. Kuroda K, Fujimoto N, Tajima S: Abnormal accumulation of inter-α-trypsin inhibitor and hyaluronic acid in lichen sclerosus. J Cutan Pathol 2005;32:137-140
7. Oyama N, Chan I, Neill SM, et al: Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 2003;362:118-123
8. Chan I: The role of extracellular matrix protein 1 in human skin. Clin Exp Dermatol 2004;29:52-56
9. Kadler KE, Holmes DF, Trotter JA, et al: Collagen fibril formation. Biochem J 1996;316:1-11
10. Landolt RM, Vaughan L, Winterhalter KH, et al: Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development 1995;121:2303-2312
11. Iozzo RV: Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998;67:609-652
12. Daugaard S, Strange L, Schiodt T: Immunohistochemical staining for chondroitin sulphate and keratin sulphate: An evaluation of two monoclonal antibodies. Histochemistry 1991;95:585-589
13. Willen MD, Sorrell JM, Lekan CC, et al: Patterns of glycosaminoglycan/ proteoglycan immunostaining in human skin during aging. J Invest Dermatol 1991;96:968-974
14. Bernstein EF, Fisher LW, Li K, et al: Differential expression of the versican and decorin genes in photoaged and sun-protected skin: Comparison by immunohistochemical and northern analyses. Lab Invest 1995;72:662-669
15. Carrino DA, Sorrell JM, Caplan AI: Age-related changes in the proteoglycans of human skin. Arch Biochem Biophys 2000;373:91-101
16. Bezerra LR, Feldner PC Jr, Kati LM, et al: Sulfated glycosaminoglycans of the vagina and perineal skin in pre- and postmenopausal women, according to genital prolapse stage. Int Urogynecol J Pelvic Floor Dysfunct 2004;15:266-271
17. Yamane Y, Yaoita H, Couchman JR: Basement membrane proteoglycans are of epithelial origin in rodent skin. J Invest Dermatol 1996;106:531-537
18. Couchman JR, Kapoor R, Sthanam M, et al: Perlecan and basement membrane-chondroitin sulfate proteoglycan (bamacan) are two basement membrane chondroitin/dermatan sulfate proteoglycans in the Engelbreth-Holm-Swarm tumor matrix. J Biol Chem 1996;271:9595-9602
19. Imai K, Hiramatsu A, Fukushima D, et al: Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J 1997;322:809-814
20. Reed CC, Iozzo RV: The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj J 2002;19:249-255
21. Frances C, Wechsler J, Meimon G , et al: Investigation of intercellular matrix macromolecules involved in lichen sclerosus. Acta Derm Venereol 1983;63:483-490
22. Kint A, Geerts ML: Lichen sclerosus et atrophicus: An electron microscopic study. J Cutan Pathol 1975;2:30-34
23. Pullkinen L, Kainulainen K, Krusius T, et al: Deficient expression of the gene coding for decorin in a lethal form of Marfan syndrome. J Biol Chem 1990;265:17780-17785
24. Beavan LA, Quentin-Hoffmann E, Schonherr E, et al: Deficient expression of decorin in infantile progeroid patients. J Biol Chem 1993;268:9856-9862
25. Danielson KG, Baribault H, Holmes DF, et al: Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997;136:729-743
26. Wu J, Utani A, Endo H, et al: Deficiency of the decorin core protein in the variant form of Ehlers-Danlos syndrome with chronic skin ulcer. J Dermatol Sci 2001;27:95-103
27. Ghose T, Landrigan P, Asif A: Localization of immunoglobulin and complement in pulmonary sarcoid granulomas. Chest 1974;66:264-268
28. Peyrol S, Takiya CM, Cordier JF, et al: Organization of connective matrix of the sarcoid granuloma: Evolution and cell-matrix interactions. Ann N Y Acad Sci 1986;465:268-285
29. Cowan MA, Alexander S, Vickers HR, et al: Case of lipoid proteinosis. BMJ 1961;5251:557-560
30. Tremble P, Chiquet-Ehrismann R, Werb Z: The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol Cell 1994;5:439-453
31. Bovo AC, da Silva ID, Takita LC, et al: A comparative study of MMP-2 in vulvar neoplasms. Gynecol Oncol 2004;93:454-457
32. Merle B, Durussel L, Delmas PD, et al: Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain. J Cell Biochem 1999;75:538-546